
Joseph N Contessa MD
Central Nervous System Cancer, Head & Neck
Professor and Chair, Radiation Oncology, RWJ Medical School, NJ Medical School, and Rutgers Cancer Institute
Join to View Full Profile
195 Little Albany StreetRutgers Cancer InstituteNew Brunswick, NJ 08903
Phone+1 848-379-3011
Fax+1 732-235-6950
Dr. Contessa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph Contessa is Professor and Chair of Radiation Oncology for the Rutgers Robert Wood Johnson and New Jersey Medical Schools. He specializes in the treatment of benign and malignant brain tumors, brain tumor metastases, and tumors that arise at the base of skull. Dr. Contessa received his MD and PhD degrees from the Medical College of Virginia and completed residency training at the University of Michigan. As an attending physician at Yale he served in multiple roles including Vice Chair of the Therapeutic Radiology Department, co-Leader of there Yale Brain Tumor Center, Co-Leader of the Yale cancer Center's Radiobiology and Genome Integrity Research Program, and Director of the CNS Radiation oncology program. At the Rutgers Cancer Institute, Dr. Contessa is the Associate Director for Translational Research. His laboratory studies new approaches to improve the efficacy of radiation therapy for the treatment of malignant tumors, and his laboratory has received competitive funding from the National Cancer Institute, the National Institute of General Medical Sciences, and the American Cancer Society. In addition to this support, he has also developed partnerships with pharmaceutical companies to advance translational research in brain, lung, and and head and neck cancers. Dr. Contessa has authored several practice-changing publications in these areas, which led to election as a Fellow of the American Society for Clinical Investigation. He also serves on the editorial board of Clinical Cancer Research and has held leadership roles on NIH advisory boards, including Chair of the Drug Discovery and Molecular Pharmacology Study Section and membership on the NCI’s Head and Neck Steering Committee.
Education & Training
- University of MichiganResidency, Radiation Oncology, 2004 - 2009
- University of MichiganInternship, Internal Medicine, 2004 - 2005
- Virginia Commonwealth University School of MedicineClass of 2004
Certifications & Licensure
- CT State Medical License 2009 - 2025
- MI State Medical License 2004 - 2009
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20
Publications & Presentations
PubMed
- Redundancy of the OST catalytic subunit facilitates therapeutic targeting of N-glycosylation.Marta Baro, Hojin Lee, Vanessa Kelley, Rongliang Lou, Chatchai Phoomak
Cell Chemical Biology. 2025-06-19 - PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivity.Irma G Dominguez-Vigil, Kishore Banik, Marta Baro, Joseph N Contessa, Thomas J Hayman
Molecular Cancer Therapeutics. 2025-04-29 - Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to Kif18a Inhibition.Vanessa Kelley, Marta Baro, William Gasperi, Nicholas Ader, Hannah Lea
Biorxiv. 2025-02-24
Press Mentions
- Med School Picks Radiologist as Next Dean, plus More Leadership Moves from RadNet, Rutgers and Rad AIAugust 14th, 2025
- Faculty Entrepreneurs Receive Research Support from Blavatnik Fund for Innovation at YaleMay 21st, 2021
- Drug Blocks Zika and Dengue Viruses in StudyDecember 13th, 2017
Grant Support
- OST Inhibition in NSCLCYALE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: